Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Other financing activities (2016 - 2025)

Historic Other financing activities for Bio Key International (BKYI) over the last 15 years, with Q1 2025 value amounting to $248783.0.

  • Bio Key International's Other financing activities rose 174694.14% to $248783.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $273271.0, marking a year-over-year decrease of 6003.61%. This contributed to the annual value of $172350.0 for FY2024, which is 6929.82% down from last year.
  • As of Q1 2025, Bio Key International's Other financing activities stood at $248783.0, which was up 174694.14% from $24488.0 recorded in Q4 2024.
  • Bio Key International's 5-year Other financing activities high stood at $535933.0 for Q4 2023, and its period low was -$5228.0 during Q4 2021.
  • Moreover, its 5-year median value for Other financing activities was $24961.0 (2023), whereas its average is $113764.0.
  • Per our database at Business Quant, Bio Key International's Other financing activities plummeted by 52270000.0% in 2021 and then surged by 306748.28% in 2022.
  • Over the past 5 years, Bio Key International's Other financing activities (Quarter) stood at -$5228.0 in 2021, then soared by 3067.48% to $155140.0 in 2022, then soared by 245.45% to $535933.0 in 2023, then tumbled by 95.43% to $24488.0 in 2024, then soared by 915.94% to $248783.0 in 2025.
  • Its last three reported values are $248783.0 in Q1 2025, $24488.0 for Q4 2024, and $134392.0 during Q3 2024.